Total Funding
43
30
Total FundingSeries B raised
Growth Score
-3 pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
213938
NVIGEN is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications.
Aihua Fu: President & CEO
Guo Liang Yu: Co-Founder & InvestorPast Role: Crown Bioscience, Executive Chairman
About the Company
NVIGEN is a nanobiotechnology company revolutionizing the field of multifunctional nanoparticles for biomedical applications. Their pipeline of visionary solutions stems from our proprietary nanochemistry technology. NVIGEN was founded in the heart of Silicon Valley, from technologies that culminated from years of rigorous research at the
University of California, Berkeley, and Stanford University.
NVIGEN develops nanoparticle research reagents and devices for biomedical research applications. NVIGEN was incorporated in 2011.
Women Founded
Women Led
